上海凯宝(300039)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300039 上海凯宝

已收盘 06-12 15:00:00

{"stockData":{"symbol":"300039","market":"SZ","secType":"STK","nameCN":"上海凯宝","latestPrice":4.46,"timestamp":1781247789000,"preClose":4.36,"halted":0,"volume":17806595,"delay":0,"changeRate":0.0229,"floatShares":917000000,"shares":1046000000,"eps":0.2478,"marketStatus":"已收盘","change":0.1,"latestTime":"06-12 15:00:00","open":4.43,"high":4.46,"low":4.33,"amount":78286300,"amplitude":0.0298,"askPrice":4.46,"askSize":1743,"bidPrice":4.45,"bidSize":845,"shortable":0,"etf":0,"ttmEps":0.2478,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781487000000},"marketStatusCode":5,"adr":0,"adjPreClose":4.36,"symbolType":"stock","openAndCloseTimeList":[[1781227800000,1781235000000],[1781240400000,1781247600000]],"highLimit":4.8,"lowLimit":3.92,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1046000000,"isCdr":false,"pbRate":0.98,"roa":"--","peRate":17.998386,"roe":"5.66%","epsLYR":0.2663,"committee":-0.527523,"marketValue":4665000000,"turnoverRate":0.0194,"status":0,"floatMarketCap":4089000000},"requestUrl":"/m/hq/s/300039","defaultTab":"news","newsList":[{"id":"2642264744","title":"上海凯宝最新公告：控股股东及部分董事高管拟合计增持不低于150万元股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2642264744","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642264744?lang=zh_cn&edition=full","pubTime":"2026-06-12 18:19","pubTimestamp":1781259584,"startTime":"0","endTime":"0","summary":"上海凯宝(300039.SZ)公告称，公司控股股东、实际控制人穆竟伟及部分董事、高级管理人员拟自公告披露之日起6个月内，以集中竞价交易方式增持公司股份，合计增持金额不低于150万元。其中，穆竟伟拟增持不低于100万元，董事王国明拟增持不低于30万元，董事、董事会秘书任立旺拟增持不低于20万元。本次增持不设定价格区间，资金来源为自有或自筹资金。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061200029270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300039","BK0188","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637318596","title":"上海凯宝（300039）披露2025年年度权益分派实施公告，5月22日股价上涨0.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637318596","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637318596?lang=zh_cn&edition=full","pubTime":"2026-05-22 17:44","pubTimestamp":1779443063,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，上海凯宝报收于5.59元，较前一交易日上涨0.54%，最新总市值为58.47亿元。近日，上海凯宝药业股份有限公司发布《2025年年度权益分派实施公告》。公司以总股本1,046,000,000股为基数，向全体股东每10股派发现金红利1.00元（含税）。本次权益分派股权登记日为2026年5月28日，除权除息日为2026年5月29日。分配方案实施前后公司总股本未发生变化，实际分配比例与审议结果一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200034509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300039","BK0188","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635747502","title":"股市必读：上海凯宝（300039）5月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2635747502","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635747502?lang=zh_cn&edition=full","pubTime":"2026-05-15 02:11","pubTimestamp":1778782295,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，上海凯宝报收于5.62元，下跌2.09%，换手率1.08%，成交量9.87万手，成交额5599.87万元。其对于多种病毒性流行疾病引发的肺部感染与发热具有良好的治疗作用。截至目前，对公司经营业绩无重大影响。当日关注点来自交易信息汇总：5月14日主力资金净流出1664.33万元，散户资金净流入1069.33万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500001735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0188","300039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635794096","title":"上海凯宝：控股子公司凯合交于2026年1月取得水胶体敷料医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2635794096","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635794096?lang=zh_cn&edition=full","pubTime":"2026-05-14 16:18","pubTimestamp":1778746687,"startTime":"0","endTime":"0","summary":"证券之星消息，上海凯宝05月14日在投资者关系平台上答复投资者关心的问题。请明确说明原因及后续披露计划。公司控股子公司凯合交于2026年1月取得水胶体敷料医疗器械注册证，目前正按既定规划推进该产品的市场布局及推广工作。截至目前，对公司经营业绩无重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400028120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK1574","09996","159883","BK0188","BK1583","BK1100","BK0239","300039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635794625","title":"上海凯宝：临床文献显示可以用于肾综合征出血热的治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2635794625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635794625?lang=zh_cn&edition=full","pubTime":"2026-05-14 16:06","pubTimestamp":1778745965,"startTime":"0","endTime":"0","summary":"其对于多种病毒性流行疾病引发的肺部感染与发热具有良好的治疗作用。临床文献显示可以用于肾综合征出血热的治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400026600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0188","300039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632727406","title":"每周股票复盘：上海凯宝（300039）股东户数增2.73%，营收降29.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632727406","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632727406?lang=zh_cn&edition=full","pubTime":"2026-05-03 04:58","pubTimestamp":1777755489,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，上海凯宝报收于5.78元，较上周的5.79元下跌0.17%。本周，上海凯宝4月29日盘中最高价报5.82元。上海凯宝当前最新总市值60.46亿元，在中药板块市值排名37/66，在两市A股市值排名3032/5200。业绩披露要点：2026年一季度主营收入2.83亿元，同比下降29.3%。股本股东变化股东户数变动截至2026年3月31日，公司股东户数为4.84万户，较12月31日增加1286.0户，增幅2.73%。户均持股数量由上期的2.22万股减少至2.16万股，户均持股市值为12.73万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631607537","title":"股市必读：上海凯宝年报 - 第四季度单季净利润同比下降42.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631607537","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631607537?lang=zh_cn&edition=full","pubTime":"2026-04-29 06:56","pubTimestamp":1777416996,"startTime":"0","endTime":"0","summary":"来自股本股东变化：截至2026年3月31日，公司股东户数环比增长2.73%，户均持股数量下降至2.16万股。股本股东变化股东户数变动近日上海凯宝披露，截至2026年3月31日公司股东户数为4.84万户，较12月31日增加1286.0户，增幅为2.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900017201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630104453","title":"图解上海凯宝一季报：第一季度单季净利润同比下降23.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630104453","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630104453?lang=zh_cn&edition=full","pubTime":"2026-04-28 04:39","pubTimestamp":1777322373,"startTime":"0","endTime":"0","summary":"证券之星消息，上海凯宝2026年一季报显示，一季度公司主营收入2.83亿元，同比下降29.3%；归母净利润6486.59万元，同比下降23.05%；扣非净利润6410.31万元，同比下降21.66%；负债率8.14%，投资收益125.96万元，财务费用-719.97万元，毛利率80.82%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800012573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628245332","title":"股市必读：上海凯宝（300039）4月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2628245332","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628245332?lang=zh_cn&edition=full","pubTime":"2026-04-17 03:01","pubTimestamp":1776366078,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘，上海凯宝报收于6.01元，上涨0.0%，换手率1.46%，成交量13.41万手，成交额8009.75万元。董秘最新回复投资者： 请问贵司有无提前公布年报季报的计划？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700003422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","300039","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618345995","title":"上海凯宝：痰热清注射液、痰热清胶囊说明书已完成合规修订","url":"https://stock-news.laohu8.com/highlight/detail?id=2618345995","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618345995?lang=zh_cn&edition=full","pubTime":"2026-03-11 09:03","pubTimestamp":1773191011,"startTime":"0","endTime":"0","summary":"证券之星消息，上海凯宝03月10日在投资者关系平台上答复投资者关心的问题。公司核心产品痰热清注射液、痰热清胶囊说明书中不良反应、禁忌、注意事项已根据上市后不良反应监测数据完成合规修订，不存在“尚不明确”的情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260311/32059236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300039","BK0239","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618953979","title":"上海凯宝：目前公司暂无减肥药相关产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2618953979","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618953979?lang=zh_cn&edition=full","pubTime":"2026-03-11 09:03","pubTimestamp":1773191008,"startTime":"0","endTime":"0","summary":"证券之星消息，上海凯宝(300039)03月10日在投资者关系平台上答复投资者关心的问题。投资者提问：中药口服液相对安全，公司有在研发中药口服减肥药吗？如没有能建议公司研发吗？上海凯宝回复：投资者您好，目前公司暂无减肥药相关产品。感谢您的建议！为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260311/32059230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300039","BK0028","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609239173","title":"股市必读：上海凯宝（300039）2月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2609239173","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609239173?lang=zh_cn&edition=full","pubTime":"2026-02-05 01:38","pubTimestamp":1770226691,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，上海凯宝报收于6.24元，上涨0.48%，换手率1.3%，成交量11.94万手，成交额7417.12万元。董秘最新回复投资者： 公司有那么多现金拿去买理财产品，为什么不拿点钱回购公司股票注销呢！公司核心产品痰热清系列产品是否有所影响，公司有所应对措施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500000967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300039","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608358992","title":"上海凯宝：公司生产经营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2608358992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608358992?lang=zh_cn&edition=full","pubTime":"2026-02-04 15:13","pubTimestamp":1770189194,"startTime":"0","endTime":"0","summary":"证券之星消息，上海凯宝(300039)02月04日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，上海凯空，为何天天跌，年年跌，是经营出现问题了吗？谢谢回答上海凯宝回复：投资者您好，公司生产经营正常。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400019995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300039","BK0188","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518244697","title":"上海凯宝(300039.SZ)全资子公司获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2518244697","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518244697?lang=zh_cn&edition=full","pubTime":"2025-03-10 19:04","pubTimestamp":1741604677,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海凯宝(300039.SZ)公告，公司全资子公司上海凯宝新谊(新乡)药业有限公司(简称“子公司”)，近日收到国家药品监督管理局签发的多索茶碱片《药品注册证书》。多索茶碱片适用于支气管哮喘、喘息性慢性支气管炎及其他支气管痉挛引起的呼吸困难。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259927.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0239","BK0188","300039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512315365","title":"上海凯宝：公司生产经营正常，不存在应披露未披露事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2512315365","media":"证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512315365?lang=zh_cn&edition=full","pubTime":"2025-02-18 18:37","pubTimestamp":1739875020,"startTime":"0","endTime":"0","summary":"证券日报网讯上海凯宝2月18日在互动平台回答投资者提问时表示，公司始终将产品质量与安全作为企业发展的第一要务，坚持“质量、创新、品牌”三核驱动现代中药高质量发展管理模式。截至目前，公司生产经营正常，不存在应披露未披露事项。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-02-18/doc-inekxfhx6959159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0188","300039","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512182341","title":"上海凯宝：截至目前优欣定项目处于III期临床研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2512182341","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512182341?lang=zh_cn&edition=full","pubTime":"2025-02-18 12:09","pubTimestamp":1739851740,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 有投资者向上海凯宝提问， 请问贵公司的优欣定开发的最近进度到哪里了？？公司回答表示，投资者您好，截至目前优欣定项目处于III期临床研究阶段。后续达到披露节点将及时予以公告。感谢您的关注！\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-02-18/doc-inekwqmn6824696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","300039","BK0188","III","BK0239","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511679135","title":"【上海凯宝在海南投资新设医疗科技公司】 公开资料显示，近日，海南凯交醇医疗科技有限公司成立，法定代表人为张小利，注册资本100万元，经营范围包含：第二类医疗器械生产；第三类医疗器械生产；第三类医疗器械经营等。股权数据显示，该公司由上海凯宝旗下上海凯合交医疗科技有限公司全资持股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511679135","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511679135?lang=zh_cn&edition=full","pubTime":"2025-02-13 13:55","pubTimestamp":1739426144,"startTime":"0","endTime":"0","summary":"公开资料显示，近日，海南凯交醇医疗科技有限公司成立，法定代表人为张小利，注册资本100万元，经营范围包含：第二类医疗器械生产；第三类医疗器械生产；第三类医疗器械经营等。股权数据显示，该公司由上海凯宝旗下上海凯合交医疗科技有限公司全资持股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/13135548133064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0028","BK1222","09997","BK1583","BK0188","159891","300039","09996","BK1574","BK1100","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509011794","title":"上海凯宝最新公告：获得苓桂术甘汤颗粒《药品注册证书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2509011794","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509011794?lang=zh_cn&edition=full","pubTime":"2025-02-07 17:04","pubTimestamp":1738919057,"startTime":"0","endTime":"0","summary":"上海凯宝药业股份有限公司近日收到国家药品监督管理局签发的苓桂术甘汤颗粒《药品注册证书》。该药品为中药3.1类，功能主治为温阳化饮，健脾利湿，用于中阳不足之痰饮。此次获得药品注册证书，将进一步丰富公司产品线，提升市场竞争力，促进古代经典名方新药转化及其在现代临床中的广泛应用。但该产品的生产和销售受国家政策、市场环境等因素影响，具有不确定性。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025020700026351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","300039","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509996117","title":"上海凯宝(300039.SZ)：苓桂术甘汤颗粒完成药品注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2509996117","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509996117?lang=zh_cn&edition=full","pubTime":"2025-02-07 16:24","pubTimestamp":1738916647,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海凯宝(300039.SZ)公告，公司近日收到国家药品监督管理局签发的苓桂术甘汤颗粒《药品注册证书》。公告显示，苓桂术甘汤颗粒的功能主治为：温阳化饮，健脾利湿。用于中阳不足之痰饮。症见胸胁支满，目眩心悸，短气而咳，舌苔白滑，脉弦滑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1247083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"上海凯宝(300039.SZ)：苓桂术甘汤颗粒完成药品注册","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0239","BK0188","300039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504406617","title":"【上海凯宝：获得药品注册证书】上海凯宝公告，公司近日收到国家药品监督管理局签发的一贯煎颗粒《药品注册证书》。一贯煎颗粒为处方药，规格为每袋相当于饮片7.77g，每袋装8g，每盒装20袋，药品有效期为24个月。该药品的功能主治为滋阴疏肝，用于肝阴不足，血燥气郁证，症见胸脘胁痛，吞酸吐苦，咽干口燥，舌红少津，脉细弦。亦治疝气瘕聚。获得药品注册证书有助于提升公司产品的市场竞争力，促进古代经典名方新药转化及其在现代临床中的广泛应用。","url":"https://stock-news.laohu8.com/highlight/detail?id=2504406617","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504406617?lang=zh_cn&edition=full","pubTime":"2025-01-20 19:34","pubTimestamp":1737372851,"startTime":"0","endTime":"0","summary":"上海凯宝公告，公司近日收到国家药品监督管理局签发的一贯煎颗粒《药品注册证书》。一贯煎颗粒为处方药，规格为每袋相当于饮片7.77g，每袋装8g，每盒装20袋，药品有效期为24个月。该药品的功能主治为滋阴疏肝，用于肝阴不足，血燥气郁证，症见胸脘胁痛，吞酸吐苦，咽干口燥，舌红少津，脉细弦。亦治疝气瘕聚。获得药品注册证书有助于提升公司产品的市场竞争力，促进古代经典名方新药转化及其在现代临床中的广泛应用。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/20193447619334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0188","BK0028","BK0239","300039"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781364651859,"stockEarnings":[{"period":"1week","weight":-0.1255},{"period":"1month","weight":-0.2082},{"period":"3month","weight":-0.2888},{"period":"6month","weight":-0.2728},{"period":"1year","weight":-0.2809},{"period":"ytd","weight":-0.2464}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0497},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0366},{"period":"1year","weight":0.1848},{"period":"ytd","weight":0.0158}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海凯宝药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"48413人(较上一季度增加2.73%)","perCapita":"18939股","listingDate":"2010-01-08","address":"上海市奉贤区工业综合开发区程普路88号","registeredCapital":"104600万元","survey":"　　上海凯宝药业股份有限公司的主营业务是现代中药研发、生产、销售。公司的主要产品是针剂、胶囊剂、片剂。公司是全国首批通过新版GMP认证的中药企业、国家级绿色工厂示范企业、上海市智能工厂。","listedPrice":38},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"上海凯宝(300039)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供上海凯宝(300039)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"上海凯宝,300039,上海凯宝股票,上海凯宝股票老虎,上海凯宝股票老虎国际,上海凯宝行情,上海凯宝股票行情,上海凯宝股价,上海凯宝股市,上海凯宝股票价格,上海凯宝股票交易,上海凯宝股票购买,上海凯宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"上海凯宝(300039)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供上海凯宝(300039)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}